These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6130916)
1. Disposition and metabolism of codorphone in the rat, dog, and man. Leeling JL; Evans JV; Helms RJ; Ryerson BA Drug Metab Dispos; 1982; 10(6):649-53. PubMed ID: 6130916 [TBL] [Abstract][Full Text] [Related]
2. Comparative metabolism of hydrocodone in man, rat, guinea pig, rabbit, and dog. Cone EJ; Darwin WD; Gorodetzky CW; Tan T Drug Metab Dispos; 1978; 6(4):488-93. PubMed ID: 28931 [TBL] [Abstract][Full Text] [Related]
3. The comparative metabolism and disposition of penfluridol-3H in the rat, rabbit, dog, and man. Grindel JM; Migdalof BH; Cressman WA Drug Metab Dispos; 1979; 7(5):325-9. PubMed ID: 40775 [TBL] [Abstract][Full Text] [Related]
4. Physiologic disposition of H3-cyclazocine in nontolerant, tolerant and abstinent dogs. Mulé SJ; Gorodetzky CW J Pharmacol Exp Ther; 1966 Dec; 154(3):632-45. PubMed ID: 5951605 [No Abstract] [Full Text] [Related]
5. Methodology for the identification of the urinary metabolites of the analgesic-narcotic antagonist, codorphone, by gas chromatography mass spectrometry. Evans JV; Leeling JL; Helms RJ Biomed Mass Spectrom; 1982 May; 9(5):191-200. PubMed ID: 6124285 [TBL] [Abstract][Full Text] [Related]
6. Species differences in the disposition and metabolism of 6,11-dihydro-11-oxodibenz[be]oxepin-2-acetic acid (isoxepac) in rat, rabbit, dog, rhesus monkey, and man. Illing HP; Fromson JM Drug Metab Dispos; 1978; 6(5):510-7. PubMed ID: 30600 [TBL] [Abstract][Full Text] [Related]
7. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs. Meuldermans W; Hendrickx J; Lauwers W; Swysen E; Hurkmans R; Knaeps F; Woestenborghs R; Heykants J Drug Metab Dispos; 1984; 12(6):772-81. PubMed ID: 6150829 [TBL] [Abstract][Full Text] [Related]
8. Physiological disposition and metabolism of (3H)bitolterol in man and dog. Shargel L; Dorrbecker SA Drug Metab Dispos; 1976; 4(1):72-8. PubMed ID: 3404 [TBL] [Abstract][Full Text] [Related]
9. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs. Prakash C; Cui D; Potchoiba MJ; Butler T Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205 [TBL] [Abstract][Full Text] [Related]
10. The disposition of 3-methyl-2,3-dihydro-9H-isoxazolo[3,2-b]-quinazolin-9-one (W-2451). Kucharczyk N; Ballard F; Yang J; Myers G; Sofia RD Arch Int Pharmacodyn Ther; 1979 Jun; 239(2):180-94. PubMed ID: 114130 [TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro metabolism studies on a class III antiarrhythmic agent. Vickers S; Duncan CA; Kari PH; Homnick CF; Elliott JM; Pitzenberger SM; Hichens M; Vyas KP Drug Metab Dispos; 1993; 21(3):467-73. PubMed ID: 8100503 [TBL] [Abstract][Full Text] [Related]
12. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans. Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130 [TBL] [Abstract][Full Text] [Related]
13. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs. Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948 [TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs. Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279 [TBL] [Abstract][Full Text] [Related]
16. The pharmacology of TR5109, a new narcotic agonist/antagonist analgesic. Howes JF; Osgood PF; Razdan RK; Moreno F; Castro A; Villareal J NIDA Res Monogr; 1979; 27():99-105. PubMed ID: 121369 [No Abstract] [Full Text] [Related]
17. Biotransformation of bromperidol in rat, dog, and man. Wong FA; Bateman CP; Shaw CJ; Patrick JE Drug Metab Dispos; 1983; 11(4):301-7. PubMed ID: 6137334 [TBL] [Abstract][Full Text] [Related]
18. Metabolism of the enantiomers of 2-hydroxy-N-cyclopropylmethylmorphinan in dog and man. Vane FM; Ellis DH; Rao J; Petrin M; Blount JF; Mohacsi E; Szuna A; Kamm JJ Biomed Mass Spectrom; 1978 Aug; 5(8):498-507. PubMed ID: 687784 [TBL] [Abstract][Full Text] [Related]
19. Disposition of the opioid antagonist, LY255582, in rats and dogs. Swanson SP; Catlow J; Pohland RC; Chay SH; Johnson T Drug Metab Dispos; 1995 Sep; 23(9):916-21. PubMed ID: 8565781 [TBL] [Abstract][Full Text] [Related]
20. The disposition and metabolism of 5-(4,5-dihydro-2-phenylbenz[e]indol-3-yl)salicylic acid (fendosal) in the rat, mouse, rabbit, do, rhesus monkey, and man. Warrander A; Metcalf R; Fromson JM Drug Metab Dispos; 1981; 9(2):161-7. PubMed ID: 6113117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]